NCT05942391

Brief Summary

The goal of this clinical trial is to compare brief-intensive cognitive-behaviour therapy (CBT) with regular weekly CBT in people with anxiety-related disorders. The main question to answer is: will brief-intensive CBT improve functioning (work, family, social) more and faster than does regular weekly CBT? Participants will be asked to follow CBT treatment (20 sessions of 45 minutes in both conditions), and participate in 7 measurements with a total duration of 5 hours over 1 year. Researchers will compare:

  • Brief-intensive CBT: 16 sessions in 2 weeks + 4 follow-up sessions within 3 months
  • Regular CBT with 20 weekly sessions in 6 months

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Apr 2024Sep 2026

First Submitted

Initial submission to the registry

June 16, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

July 12, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

April 26, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Expected
Last Updated

March 24, 2025

Status Verified

March 1, 2025

Enrollment Period

1.9 years

First QC Date

June 16, 2023

Last Update Submit

March 18, 2025

Conditions

Keywords

agoraphobiasocial anxiety disordergeneralized anxiety disorderpanic disordertraumahealth anxietyobsessive compulsive disorderCBT

Outcome Measures

Primary Outcomes (1)

  • Area Under the health and disability Curve at 6 months

    The 'area under the curve' for health and disability is based on the 36-item self-report World Health Organisation Disability Assessment Schedule (WHODAS 2.0). The WHODAS 2.0 captures the level of functioning in six domains of life: Cognition, Mobility, Self-care, Getting along, Life activities, Participation. Possible total scores of the items across all domains range 0 - 100. Lower scores indicate less disability.

    baseline, 2 weeks, 4 weeks, 2 months, 3 months, 6 months

Secondary Outcomes (17)

  • Area Under the health and disability Curve at 12 months

    baseline, 2 weeks, 4 weeks, 2 months, 3 months, 6 months, 12 months

  • Change from baseline in severity of anxiety symptoms at post-treatment

    baseline and 3 or 6 months

  • Change from baseline in severity of anxiety symptoms at 3 months

    baseline and 3 months

  • Change from baseline in severity of anxiety symptoms at 12 months

    baseline and 12 months

  • Change from baseline in severity of depressive symptoms at post-treatment

    baseline and 3 or 6 months

  • +12 more secondary outcomes

Study Arms (2)

Brief-Intensive CBT

EXPERIMENTAL

16 sessions in 2 weeks + 4 follow up sessions. The CBT consists of 16 sessions exposure therapy, spread over 4 half-days in 2 weeks, + 4 sessions within 3 months.

Behavioral: Cognitive behavioral therapy (CBT)

weekly CBT

ACTIVE COMPARATOR

20 weekly CBT sessions within 5 to 6 months. The CBT consists of exposure therapy.

Behavioral: Cognitive behavioral therapy (CBT)

Interventions

The intervention is brief-intensive, guided exposure therapy and consists of 16 sessions exposure therapy, spread over 4 half-days in 2 weeks plus 4 follow-up sessions within 3 months.

Also known as: exposure therapy
Brief-Intensive CBTweekly CBT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older;
  • Reaching out for mental health care for one of the following disorders:
  • panic disorder, agoraphobia, generalised anxiety disorder, social anxiety disorder, posttraumatic stress disorder, obsessive-compulsive disorder, health anxiety disorder.

You may not qualify if:

  • Is in need of emergency mental health care
  • Has insufficient language skills in Dutch
  • Has evident cognitive limitations
  • Has had changes in the use of medication during the last 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

GGZ inGeest, polikliniek Angst & Dwang, locatie Amstelmere

Amstelveen, Netherlands

RECRUITING

GGZ inGeest, polikliniek Angst & Dwang, locatie De Nieuwe Valerius

Amsterdam, Netherlands

RECRUITING

GGZ inGeest, polikliniek Angst & Dwang, locatie Zuiderpoort

Haarlem, Netherlands

RECRUITING

GGZ Centraal, Algemeen Specialistische Polikliniek

Hilversum, Netherlands

RECRUITING

GGZ inGeest, polikliniek Angst & Dwang, locatie Spaarnepoort

Hoofddorp, Netherlands

RECRUITING

Altrecht Academisch Angstcentrum

Utrecht, Netherlands

RECRUITING

MeSH Terms

Conditions

Anxiety DisordersObsessive-Compulsive DisorderStress Disorders, Post-TraumaticHypochondriasisAgoraphobiaPhobia, SocialGeneralized Anxiety DisorderPanic DisorderWounds and Injuries

Interventions

Cognitive Behavioral TherapyImplosive Therapy

Condition Hierarchy (Ancestors)

Mental DisordersStress Disorders, TraumaticTrauma and Stressor Related DisordersSomatoform DisordersPhobic Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesDesensitization, Psychologic

Study Officials

  • Neeltje Batelaan, PhD

    Amsterdam UMC

    STUDY DIRECTOR

Central Study Contacts

Adrie Seldenrijk, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: a parallel-group randomised controlled intervention study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 16, 2023

First Posted

July 12, 2023

Study Start

April 26, 2024

Primary Completion

March 31, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

March 24, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations